相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model
Liang Zhang et al.
CANCER LETTERS (2007)
Targeting TRAIL agonistic receptors for cancer therapy
Carmelo Carlo-Stella et al.
CLINICAL CANCER RESEARCH (2007)
Therapeutic expression of an anti-death receptor 5 single-chain fixed-variable region prevents tumor growth in mice
Juan Shi et al.
CANCER RESEARCH (2006)
Adenovirus-mediated transfection of caspase-8 sensitizes hepatocellular carcinoma to TRAIL- and chemotherapeutic agent-induced cell death
Yumi Yamaguchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model
JM Straughn et al.
GYNECOLOGIC ONCOLOGY (2006)
c-FLIP inhibits chemotherapy-induced colorectal cancer cell death
DB Longley et al.
ONCOGENE (2006)
Persistent inhibition of FLIPL expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cells
M Flahaut et al.
APOPTOSIS (2006)
A novel anti-human DR5 monoclonal antibody with tumoricidal activity induces caspase-dependent and caspase-independent cell death
YB Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Perturbation of the tumor necrosis factor-related apoptosis-inducing ligand cascade in ovarian cancer:: Overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5
P Horak et al.
CLINICAL CANCER RESEARCH (2005)
c-FLIPR, a new regulator of death receptor-induced apoptosis
A Golks et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice
J Shi et al.
CANCER RESEARCH (2005)
Overexpression of cellular FLICE-inhibitory protein (FLIP) in gastric adenocarcinoma
XD Zhou et al.
CLINICAL SCIENCE (2004)
Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy
K Takeda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas
JJ Koornstra et al.
JOURNAL OF PATHOLOGY (2003)
Apo2L/TRAIL and its death and decoy receptors
HN LeBlanc et al.
CELL DEATH AND DIFFERENTIATION (2003)
Novel approaches to the treatment of non-small cell lung cancer
CG Ferreira et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
K Ichikawa et al.
NATURE MEDICINE (2001)
Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4
A Chuntharapai et al.
JOURNAL OF IMMUNOLOGY (2001)
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
D Lawrence et al.
NATURE MEDICINE (2001)
Cancer statistics, 2001
RT Greenlee et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2001)
Activation of the NF-κB pathway by Caspase 8 and its homologs
PM Chaudhary et al.
ONCOGENE (2000)
Requirement for casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development
WC Yeh et al.
IMMUNITY (2000)
The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways
T Kataoka et al.
CURRENT BIOLOGY (2000)
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
M Jo et al.
NATURE MEDICINE (2000)
分享论文
